a little johnson & johnson story, page-13

abdm,

I looked at Zosano a bit further, and I reckon it's a competitor. Microneedles and some powder and they started it 8 years ago. So not OBJ tech.

And I don't see anything special in OBJ's 19/6/2007 presentation. If you mean the use of the word "biphasic", then I don't think that's significant. It's just an adjective with multiple potential uses.

And it's got me thinking that maybe GSK are leading OBJ along because GSK is competing too and just pretending to be interested to waste OBJ's time while GSK get further ahead. Not likely, but possible.